HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Elisabetta Castoldi Selected Research

Factor V Deficiency

11/2013	Antisense-based RNA therapy of factor V deficiency: in vitro and ex vivo rescue of a F5 deep-intronic splicing mutation.
1/2010	Residual platelet factor V ensures thrombin generation in patients with severe congenital factor V deficiency and mild bleeding symptoms.
11/2008	Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research network!

Elisabetta Castoldi Research Topics

Disease

12	Activated Protein C Resistance (APC Resistance) 08/2014 - 09/2002
9	Venous Thrombosis (Deep-Vein Thrombosis) 08/2014 - 05/2004
6	Hemorrhage 02/2015 - 12/2003
5	Thrombosis (Thrombus) 09/2010 - 05/2004
4	Venous Thromboembolism 01/2012 - 06/2003
3	Factor V Deficiency 11/2013 - 11/2008
3	Protein S Deficiency (Deficiency, Protein S) 09/2010 - 09/2008
2	Disease Susceptibility (Diathesis) 01/2009 - 11/2008
1	Essential Thrombocythemia 11/2008
1	Polycythemia Vera 11/2008
1	Thrombophilia 10/2005

Drug/Important Bio-Agent (IBA)

10	Factor V (Coagulation Factor V)IBA 08/2014 - 09/2002
9	Protein CIBA 08/2014 - 10/2003
9	factor V LeidenIBA 08/2014 - 06/2003
9	Thrombin FDA Link 02/2011 - 12/2003
5	Protein SIBA 09/2010 - 02/2006
2	Prothrombin (Factor II)IBA 02/2015 - 02/2006
2	lipoprotein-associated coagulation inhibitor (TFPI)IBA 01/2010 - 11/2008
1	ThrombomodulinIBA 02/2015
1	Fibrinogen (Factor I)FDA Link 08/2014
1	RNA (Ribonucleic Acid)IBA 11/2013
1	Thromboplastin (Tissue Factor)IBA 01/2012
1	platelet factor VIBA 01/2010
1	Proteins (Proteins, Gene)IBA 09/2008
1	Vitamin K FDA Link 09/2008